Group 1 - The core point of the article highlights that four funds under Baoying Fund experienced a decline of over 9% in 2025, with specific funds managed by Yao Yi and Zhang Ruolun showing significant losses [1][2] - Baoying Advantage Industry Mixed C and A funds reported declines of 15.66% and 15.32% respectively, with Yao Yi managing these funds since March 2021 after a tenure at Huatai Securities [1][2] - The top ten holdings of Baoying Advantage Industry Mixed fund include companies such as Bai Li Tianheng, Heng Rui Pharmaceutical, and WuXi AppTec, indicating a focus on the pharmaceutical sector [1] Group 2 - Baoying Brand Consumption Stock C and A funds recorded declines of 9.87% and 9.11% respectively, managed by Zhang Ruolun since August 2025 [1][2] - The Baoying Brand Consumption fund maintains a diversified portfolio across major consumer sectors, with top holdings including Kweichow Moutai, Tencent Holdings, and Haidilao [1][2] - The funds have been operational since 2019, with the Brand Consumption funds focusing on sectors like liquor, home appliances, and leisure food [1][2]

Group 1 - In 2025, four funds under the management of Baoying Fund experienced a decline of over 9% [1] - Baoying Advantage Industry Mixed C and A funds fell by 15.66% and 15.32% respectively, managed by Yao Yi, who has been with Baoying since 2017 [1] - The top ten holdings of Baoying Advantage Industry Mixed fund include companies like Hengrui Medicine and WuXi AppTec [1] Group 2 - Baoying Brand Consumption Stock C and A funds recorded declines of 9.87% and 9.11% respectively, managed by Zhang Ruolun since August 2025 [1] - The Baoying Brand Consumption fund diversifies its holdings across various consumer sectors, with top ten holdings including Kweichow Moutai and Tencent [1][2] - The funds have varying net asset values, with Baoying Advantage Industry Mixed A at 4.00 billion and Baoying Brand Consumption A at 0.38 billion [2]

Group 1 - In 2025, four funds under the management of Baoying Fund experienced a decline of over 9% [1] - The Baoying Advantage Industry Mixed C and A funds, managed by Yao Yi, fell by 15.66% and 15.32% respectively [1] - The top ten holdings of Baoying Advantage Industry Mixed fund include companies such as Bai Li Tian Heng, Heng Rui Pharmaceutical, and WuXi AppTec [1] Group 2 - The Baoying Brand Consumption Stock C and A funds, managed by Zhang Ruolun, declined by 9.87% and 9.11% respectively [2] - The Baoying Brand Consumption fund diversifies its holdings across various consumer sectors, including liquor, home appliances, and leisure food [1] - The top ten holdings of Baoying Brand Consumption fund include Kweichow Moutai, Tencent Holdings, and Haidilao [1]

Core Viewpoint - The A-share market in 2025 exhibited a clear structural bull market, with significant performance disparities among active equity funds, highlighted by the top-performing fund achieving a record annual return of 233.29% while others faced substantial losses, including the worst performer with a -19.65% return [1][4]. Group 1: Market Performance - The Shanghai Composite Index, Shenzhen Component Index, ChiNext Index, and Sci-Tech Innovation 50 Index rose by 18.41%, 29.87%, 49.57%, and 35.92% respectively in 2025 [1]. - A total of 4888 active equity products from 160 public fund institutions reported positive returns, while 144 products from 68 institutions experienced losses [1][9]. Group 2: Fund Performance Disparities - The top-performing fund, Yongying Technology Smart Selection, achieved a record annual return of 233.29%, surpassing the previous record set by Wang Yawei in 2007 [1]. - The worst-performing fund, Xinyuan Consumption Selection, recorded a -19.65% return, marking a significant gap of 252.94% from the top performer [2][4]. Group 3: Xinyuan Consumption Selection Analysis - Xinyuan Consumption Selection's poor performance is attributed to aggressive trading strategies, frequent personnel changes, and scale challenges, leading to a lack of coherent investment logic [3][5]. - The fund's industry allocation showed erratic shifts, moving from heavy investments in pharmaceuticals to technology and later to media, missing key market trends [5][6]. Group 4: Fund Manager Insights - Notable fund managers, including Wang Mingxu and Han Weijun, saw their products listed among the worst performers, with their total managed assets shrinking by over 70% compared to previous peaks [3][9][12]. - Xinyuan Consumption Selection faced a critical challenge to meet its scale assessment, needing to grow from 0.29 billion to 2 billion within three months [7][8]. Group 5: Institutional Investment Trends - Institutional ownership in Xinyuan Consumption Selection dropped from over 95% to 42.94% by mid-2025, indicating a significant withdrawal of institutional funds [7]. - The trend of multiple products from the same fund manager appearing on the loss list highlights a broader issue within the industry, affecting even previously successful managers [9][10].

Group 1 - The core point of the news is that the Baoying Advantage Industry Mixed Fund A/C has experienced declines of 10.8% and 11.1% respectively in the first ten months of this year [1] - The fund is currently managed by Yao Yi, who took over in August 2023 after Yang Siliang left the company [1] - Yang Siliang had a decade-long tenure at Baoying Fund Management, managing public funds since March 2018 until his departure [1] Group 2 - The top ten holdings of the fund in the third quarter include companies such as Baile Tianheng, Heng Rui Pharmaceutical, and Kelong Pharmaceutical, indicating a shift from its previous focus on blue-chip stocks like liquor and home appliances [1] - Despite the change in holdings, the fund's performance has not shown significant improvement in the last two months [1] - The cumulative net value for Baoying Advantage Industry Mixed Fund A is reported at 3.0841, while Fund C is at 2.8839, with respective growth rates of -10.7972% and -11.0977% [2]